Protein profiles in Tc1 mice implicate novel pathway perturbations in the down syndrome brain

Human Molecular Genetics

Volumn 22, Issue 9, 2013, Pages 1709-1724

  Ahmed, Md Mahiuddin ^a   Ranjitha Dhanasekaran, A ^a   Tong, Suhong ^a   Wiseman, Frances K ^b   Fisher, Elizabeth M C ^b   Tybulewicz, Victor L J ^c   Gardiner, Katheleen J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ADENYLATE KINASE; AMYLOID BETA PROTEIN; CALCIUM BINDING PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; NEU DIFFERENTIATION FACTOR; PROTEIN PRECURSOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; ENZYME ACTIVE SITE; FEMALE; HIPPOCAMPUS; IMMEDIATE EARLY GENE; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; ORTHOLOGY; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOICHIOMETRY; TRISOMY; VIRUS ONCOGENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BRAIN; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; DOWN SYNDROME; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NERVE GROWTH FACTORS; PHOSPHORYLATION; RECEPTORS, N-METHYL-D-ASPARTATE; S100 PROTEINS; TOR SERINE-THREONINE KINASES;

MURINAE; MUS;

EID: 84875914857     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt017     Document Type: Article

References (56)

1. CDC, Centers for Disease Control and Prevention. (2006) Improved national prevalence estimates for 18 major birth defects. MMWR Morb. Mortal. Wkly. Rep., 54, 6-12.
2. Irving, C., Basu, A., Richmond, S., Burn, J. and Wren, C. (2008) Twenty-year trends in prevalence and survival of Down syndrome. Eur. J. Hum. Genet., 16, 1336-1340.
3. Chapman, R.S. and Hesketh, L.J. (2000) Behavioral phenotype of individuals with Down syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 6, 84-95.
4. Silverman, W. (2007) Down syndrome: cognitive phenotype. Ment. Retard. Dev. Disabil. Res. Rev., 13, 228-236.
5. Edgin, J.O., Mason, G.M., Allman, M.J., Capone, G.T., Deleon, I., Maslen, C., Reeves, R.H., Sherman, S.L. and Nadel, L. (2010) Development and validation of the Arizona Cognitive Test Battery for Down syndrome. J. Neurodev. Disord., 2, 149-164.
6. Benavides-Piccione, R., Ballesteros-Yanez, I., de Lagran, M.M., Elston, G., Estivill, X., Fillat, C., Defelipe, J. and Dierssen, M. (2004) On dendrites in Down syndrome and DS murine models: a spiny way to learn. Prog. Neurobiol., 74, 111-126.
7. Lott, I.T. and Dierssen, M. (2010) Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet. Neurol., 9, 623-633.
8. Capone, G., Goyal, P., Ares, W. and Lannigan, E. (2006) Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome.Am. J. Med. Genet. C. Semin. Med. Genet., 142C, 158-172.
9. Sturgeon, X. and Gardiner, K. (2011) Comparative transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse genomic regions. Mam. Genome, 22, 61-71.
10. O'Doherty, A., Ruf, S., Mulligan, C., Hildreth, V., Errington, M.L., Cooke, S., Sesay, A., Modino, S., Vanes, L., Hernandez, D. et al. (2005) An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science, 309, 2033-2037.
11. Kuhn, S., Ingham, N., Pearson, S., Gribble, S.M., Clayton, S., Steel, K.P. and Marcotti, W. (2012) Auditory function in the Tc1 mouse model of down syndrome suggests a limited region of human chromosome 21 involved in otitis media. PLoS One, 7, e31433.
12. Morice, E., Andreae, L.C., Cooke, S.F., Vanes, L., Fisher, E.M., Tybulewicz, V.L. and Bliss, T.V. (2008) Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learn Mem., 15, 492-500.
13. Ahmed, M.M., Sturgeon, X., Ellison, M., Davisson, M.T. and Gardiner, K.J. (2012) Loss of correlations among proteins in brains of the Ts65Dn mouse model of Down syndrome. J. Prot. Res., 11, 1251-1263.
14. Qi, H., Juo, P., Masuda-Robens, J., Caloca, M.J., Zhou, H., Stone, N., Kazanietz, M.G. and Chou, M.M. (2001) Caspase-mediated cleavage of the TIAM1 guanine nucleotide exchange factor during apoptosis. Cell Growth Differ., 12, 603-611.
15. Sheppard, O., Plattner, F., Rubin, A., Slender, A., Linehan, J.M., Brandner, S., Tybulewicz, V.L., Fisher, E.M. and Wiseman, F.K. (2012) Altered regulation of tau phosphorylation in a mouse model of down syndrome aging. Neurobiol. Aging, 33, 828.e31-828.e44.
16. Allison, J.G., Das, P.M., Ma, J., Inglis, F.M. and Jones, F.E. (2011) The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons. Neurosci. Res., 70, 155-163.
17. Wong, K.A., Wilson, J., Russo, A., Wang, L., Okur, M.N., Wang, X., Martin, N.P., Scappini, E., Carnegie, G.K. and O'Bryan, J.P. (2012) Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. PLoS One., 7, e36023.
18. Harashima, C., Jacobowitz, D.M., Witta, J., Borke, R.C., Best, T.K., Siarey, R.J. and Galdzicki, Z. (2006) Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome. J. Comp. Neurol., 494, 815-833.
19. Braudeau, J., Dauphinot, L., Duchon, A., Loistron, A., Dodd, R.H., Hérault, Y., Delatour, B. and Potier, M.C. (2011) Chronic treatment with a promnesiant GABA-A a5-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a Down syndrome mouse model. Adv. Pharmacol. Sci., 2011, 153218.
20. Troca-Marín, J.A., Alves-Sampaio, A. and Montesinos, M.L. (2011) An increase in basal BDNF provokes hyperactivation of the Akt-mammalian target of rapamycin pathway and deregulation of local dendritic translation in a mouse model of Down's syndrome. J. Neurosci., 31, 9445-9455.
21. Nishimura, T., Yamaguchi, T., Tokunaga, A., Hara, A., Hamaguchi, T., Kato, K., Iwamatsu, A., Okano, H. and Kaibuchi, K. (2006) Role of numb in dendritic spine development with a Cdc42 GEF intersectin and EphB2. Mol. Biol. Cell., 17, 1273-1285.
22. Mei, L. and Xiong, W.C. (2008) Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci., 9, 437-452.
23. Siddiqui, A., Lacroix, T., Stasko, M., Costa, A.C. and Gardiner, K. (2008) Molecular response of the Ts65Dn and Ts1Cje mouse models of Down syndrome to the NMDA receptor antagonist, MK-801. Genes Brain Behav., 7, 810-819.
24. Nguyen, C.D., Costa, A.C., Cios, K.J. and Gardiner, K.J. (2011) Machine learning methods predict locomotor response to MK-801 in mouse models of down syndrome. J. Neurogenet., 25, 40-51.
25. Samuels, I.S., Saitta, S.C. and Landreth, G.E. (2009) MAP'ing CNS development and cognition: an ERKsome process. Neuron, 61, 160-167.
26. Ehler, E., van Leeuwen, F., Collard, J.G. and Salinas, P.C. (1997) Expression of Tiam-1 in the developing brain suggests a role for the Tiam-1-Rac signaling pathway in cell migration and neurite outgrowth. Mol. Cell Neurosci., 9, 1-12.
27. Tolias, K.F., Bikoff, J.B., Burette, A., Paradis, S., Harrar, D., Tavazoie, S., Weinberg, R.J. and Greenberg, M.E. (2005) The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines. Neuron, 45, 525-538.
28. Tolias, K.F., Bikoff, J.B., Kane, C.G., Tolias, C.S., Hu, L. and Greenberg,M.E. (2007) The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development. Proc. Natl Acad. Sci. USA, 104, 7265-7270.
29. Cousins, S.L., Hoey, S.E., Anne Stephenson, F. and Perkinton, M.S. (2009) Amyloid precursor protein 695 associates with assembled NR2Aand NR2B-containing NMDA receptors to result in the enhancement of their cell surface delivery. J. Neurochem., 111, 1501-1513.
30. Vilardell, M., Rasche, A., Thormann, A.,Maschke-Dutz, E., Pérez-Jurado, L.A., Lehrach, H. and Herwig, R. (2011) Meta-analysis of heterogeneous Down syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics, 12, 229-245.
31. Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W. and Selbach, M. (2011) Global quantification of mammalian gene expression control. Nature, 473, 337-342.
32. Stingele, S., Stoehr, G., Peplowska, K., Cox, J., Mann, M. and Storchova, Z. (2012) Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol., 8, 608.
33. Wang, Y., Mulligan, C., Denyer, G., Delom, F., Dagna-Bricarelli, F., Tybulewicz, V.L., Fisher, E.M., Griffiths, W.J., Nizetic, D. and Groet, J. (2009) Quantitative proteomics characterization of a mouse embryonic stem cell model of Down syndrome. Mol. Cell. Proteomics, 8, 585-595.
34. Cohen, P. and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol., 2, 769-776.
35. Sturgeon, X., Le, T., Ahmed, M.M. and Gardiner, K.J. (2012) Pathways to cognitive deficits in Down syndrome. Prog. Brain Res., 197, 73-100.
36. Spellman, C., Ahmed, M.M., Dubach, D. and Gardiner, K.J. (2012) Expression of trisomic proteins in Down syndrome model systems. Gene, 512, 219-225.
37. Vullhorst, D., Neddens, J., Karavanova, I., Tricoire, L., Petralia, R.S., McBain, C.J. and Buonanno, A. (2009) Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J. Neurosci., 29, 12255-12264.
38. Chen, Y.J., Zhang, M., Yin, D.M., Wen, L., Ting, A., Wang, P., Lu, Y.S., Zhu, X.H., Li, S.J., Wu, C.Y. et al. (2010) ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc. Natl Acad. Sci. USA, 107, 21818-21823.
39. Kaphzan, H., Hernandez, P., Jung, J.I., Cowansage, K.K., Deinhardt, K., Chao, M.V., Abel, T. and Klann, E. (2012) Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors. Biol. Psychiatry, 72, 182-190.
40. Woo, R.S., Lee, J.H., Yu, H.N., Song, D.Y. and Baik, T.K. (2011) Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease. Anat. Cell Biol., 44, 116-127.
41. Cai, Z., Yan, L.J., Li, K., Quazi, S.H. and Zhao, B. (2012) Roles of AMP-activated protein kinase in Alzheimer's disease. Neuromolecular Med., 14, 1-14.
42. Potter, W.B., O'Riordan, K.J., Barnett, D., Osting, S.M., Wagoner, M., Burger, C. and Roopra, A. (2010) Metabolic regulation of neuronal plasticity by the energy sensor AMPK. PLoS One, 5, e8996.
43. Chen, L., Xu, B., Liu, L., Luo, Y., Yin, J., Zhou, H., Chen, W., Shen, T., Han, X. and Huang, S. (2010) Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. Lab. Invest., 90, 762-773.
44. Kondo, T., Sharp, F.R., Honkaniemi, J., Mikawa, S., Epstein, C.J. and Chan, P.H. (1997) DNA fragmentation and prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase. J. Cereb. Blood Flow Metab., 7, 241-256.
45. Chaum, E., Yin, J. and Lang, J.C. (2011) Molecular responses transduced by serial oxidative stress in the retinal pigment epithelium: feedback control modeling of gene expression. Neurochem. Res., 36, 574-582.
46. Kaur, J. and Bansal, M.P. (2008) Effect of vitamin E on alcohol-induced changes in oxidative stress and expression of transcription factors NFkappaB and AP-1 in mice brain cerebral hemispheres. Indian J. Exp. Biol., 46, 562-567.
47. Sun, L.Y., Steinbaugh, M.J., Masternak, M.M., Bartke, A. and Miller, R.A. (2009) Fibroblasts from long-lived mutant mice show diminished ERK1/2 phosphorylation but exaggerated induction of immediate early genes. Free Radic. Biol. Med., 47, 1753-1761.
48. Tlili, A., Hoischen, A., Ripoll, C., Benabou, E., Badel, A., Ronan, A., Touraine, R., Grattau, Y., Stora, S., van Bon, B. et al. (2012) BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from Down syndrome patients. Mol. Neurobiol., 46, 297-303.
49. Duchon, A., Raveau, M., Chevalier, C., Nalesso, V., Sharp, A.J. and Herault, Y. (2011) Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome, 22, 674-684.
50. Reinholdt, L.G., Ding, Y., Gilbert, G.J., Czechanski, A., Solzak, J.P., Roper, R.J., Johnson, M.T., Donahue, L.R., Lutz, C. and Davisson, M.T. (2011) Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.Mamm. Genome, 22, 685-691.
51. Chen, J.S., Su, I.J., Leu, Y.W., Young, K.C. and Sun, H.S. (2012) Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer. Int. J. Cancer., 130, 1302-1313.
52. Lott, I.T., Doran, E., Nguyen, V.Q., Tournay, A., Head, E. and Gillen, D.L. (2011) Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation. Am. J. Med. Genet. A., 155A, 1939-1948.
53. Hanney, M., Prasher, V., Williams, N., Jones, E.L., Aarsland, D., Corbett, A., Lawrence, D., Yu, L.M., Tyrer, S., Francis, P.T. et al. MEADOWS trial researchers. (2012) Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet, 379, 528-536.
54. Boada, R., Hutaff-Lee, C., Schrader, A., Weitzenkamp, D., Benke, T.A., Goldson, E.J. and Costa, A.C. (2012) Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial. Transl. Psychiatry., 2, e141.
55. Ahmed, M.M. and Gardiner, K.J. (2011) Preserving protein profiles in tissue samples: differing outcomes with and without heat stabilization. J. Neurosci. Methods. 196, 99-106.
56. Svensson, M., Boren, M., Sköld, K., Fälth, M., Sjögren, B., Andersson, M., Svenningsson, P. and Andren, P.E. (2009) Heat stabilization of the tissue proteome: a new technology for improved proteomics. J. Proteome Res, 8, 974-981.